VCM
INSM icon

Voleon Capital Management’s Insmed INSM Stock Holding History

Voleon Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,883
Closed -$850K – 851
2025
Q4 		$850K Sell
4,883
-42,784
-90% -$7.81M 0.02% 470
2025
Q3 		$6.86M Buy
47,667
+42,900
+900% +$5.26M 0.17% 123
2025
Q2 		$480K Buy
+4,767
New +$364K 0.03% 327

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Voleon Capital Management's INSM Position: Q1 2026 in Review

Voleon Capital Management sold out of Insmed (INSM) in Q1 2026, closing a stake of 4,883 shares — an estimated $850K sold.

Voleon Capital Management first reported a position in INSM in Q2 2025 and held it in 3 quarters. The position peaked at $6.86M in Q3 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Voleon Capital Management reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Voleon Capital Management sold 4,883 Insmed shares in Q1 2026, an estimated $850K.
  • Voleon Capital Management first reported a position in Insmed in Q2 2025 and held it in 3 quarters.
  • Voleon Capital Management's Insmed position peaked at $6.86M in Q3 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.